dual antiplatelet therapy (DAPT)

From Aaushi
Jump to navigation Jump to search

Pharmacology

* proton pump inhibitor provides protection from GI bleeding without affecting adverse cardiovascular risk[11]

Indications

Contraindications

Benefit/risk

Management

* calculator to predict risks of ischemic events vs bleeding for continued DAPT therapy beyond 1 year after coronary stent placement[9]

More general terms

Additional terms

References

  1. Shehab N et al National Estimates of Emergency Department Visits for Hemorrhage-Related Adverse Events From Clopidogrel Plus Aspirin and From Warfarin Arch Intern Med. 2010;170(21):1926-1933 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21098354 <Internet> http://archinte.ama-assn.org/cgi/content/abstract/170/21/1926
  2. 2.0 2.1 Amin AP et al. Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status. J Am Coll Cardiol 2013 May 28; 61:2130 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23541975
    Dauerman HL. The softer side of bleeding. J Am Coll Cardiol 2013 May 28; 61:2139. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23541969
  3. 3.0 3.1 Brett AS The Pros and Cons of Dual Antiplatelet Therapy. NEJM Journal Watch. Feb 26, 2015 Massachusetts Medical Society (subscription needed) http://www.jwatch.org
    Mauri L et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014 Dec 4; 371:2155. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25399658 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1409312
    Colombo A and Chieffo A. Dual antiplatelet therapy after drug-eluting stents - How long to treat? N Engl J Med 2014 Dec 4; 371:2225. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25399657 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1413297
    Gilard M et al. Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin: ITALIC, a randomized multicenter trial. J Am Coll Cardiol. 2014 Nov 16. pii: S0735-1097(14)06970-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/25461690
    Gilard M et al. 6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: The randomized, multicenter ITALIC trial. J Am Coll Cardiol 2015 Mar 3; 65:777. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25461690 <Internet> http://www.sciencedirect.com/science/article/pii/S0735109714069708
    Elmariah S et al. Extended duration dual antiplatelet therapy and mortality: A systematic review and meta-analysis. Lancet 2014 Nov 16 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25467565 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2962052-3/abstract
  4. Bonaca MP et al Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction. N Engl J Med. March 14, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25773268 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1500857
    Keaney JF Jr Balancing the Risks and Benefits of Dual Platelet Inhibition. N Engl J Med. March 14, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25773507 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1502137
  5. 5.0 5.1 5.2 The NNT: Clopidogrel Added To Aspirin During and After a Coronary Event or a Stent Procedure. http://www.thennt.com/nnt/clopidogrel-added-to-aspirin-during-and-after-a-coronary-event-or-stenting/
  6. 6.0 6.1 6.2 The NNT: Clopidogrel Added to Aspirin to Prevent a Second Heart Attack Or Stroke. http://www.thennt.com/nnt/clopidogrel-with-aspirin-for-prevention-after-prior-heart-attack-or-stroke/
    Squizzato A, Keller T, Romualdi E, Middeldorp S Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD005158 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21249668
    Bowry AD, Brookhart MA, Choudhry NK. Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol. 2008 Apr 1;101(7):960-6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18359315
  7. 7.0 7.1 7.2 Navarese EP et al. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials. BMJ 2015 Apr 16; 350:h1618. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25883067 <Internet> http://www.bmj.com/content/350/bmj.h1618
  8. 8.0 8.1 Spencer FA et al Longer Versus Shorter Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta- analysis. Ann Intern Med. May 26, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26005909 <Internet> http://annals.org/article.aspx?articleid=2297227
  9. 9.0 9.1 Yeh RW, Secemsky E, Kereiakes DJ Individualizing Treatment Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: An Analysis of the DAPT Study. American Heart Association. 2015 Annual Meeting. Nov 10. http://www.abstractsonline.com/pp8/#!/3795/presentation/47453
    DAPT Score Calculator http://www.daptstudy.org/for-clinicians/score_calculator.htm
  10. 10.0 10.1 Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/ AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation. March 29, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27026020 <Internet> http://circ.ahajournals.org/content/early/2016/03/28/CIR.0000000000000404.full.pdf+html
    Yeh RW, Secemsky EA, Kereiakes DJ et al Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. Published online March 29, 2016. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27022822 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=2508253
  11. 11.0 11.1 11.2 11.3 11.4 11.5 11.6 11.7 Levine GN, Bates ER, Bittl JA et al 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27036918 Free full text
  12. Vaduganathan M et al. Proton-pump inhibitors reduce gastrointestinal events regardless of aspirin dose in patients requiring dual antiplatelet therapy. J Am Coll Cardiol 2016 Mar 16 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27012778
  13. 13.0 13.1 Gargiulo G, Windecker S, da Costa BR et al Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials. BMJ 2016;355:i5483 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27811064 Free full text <Internet> http://www.bmj.com/content/355/bmj.i5483
    Ball J Optimal duration of dual antiplatelet therapy after stent implantation in patients with or without diabetes. BMJ 2016;355:i5730 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27811234 <Internet> http://www.bmj.com/content/355/bmj.i5730
  14. 14.0 14.1 Palmerini T, Bacchi Reggiani L et al. Bleeding-related deaths in relation to the duration of dual- antiplatelet therapy after coronary stenting. J Am Coll Cardiol 2017 Apr 25; 69:2011. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28427576 <Internet> http://www.sciencedirect.com/science/article/pii/S0735109717306964
    Rao SV, Harrington RA. Bleeding and mortality with dual antiplatelet therapy: The Rashomon effect. J Am Coll Cardiol 2017 Apr 25; 69:2023. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28427577 <Internet> http://www.sciencedirect.com/science/article/pii/S0735109717360187
  15. 15.0 15.1 15.2 Hilkens NA, Algra A, Kappelle LJ, et al. Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke. Neurology 2018 Feb 20; 90:e683 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29374102 Free PMC Article <Internet> http://n.neurology.org/content/90/8/e683
  16. 16.0 16.1 Kedhi E, Fabris E, van der Ent M et al Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial. BMJ 2018;363:k3793 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30279197 Free Article https://www.bmj.com/content/363/bmj.k3793
  17. Levine GN, Bates ER, Bittl JA et al 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243-1275. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27751237
  18. 18.0 18.1 Watanabe H, Domei R, Morimoto T et al Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. JAMA. 2019;321(24):2414-2427. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31237644 https://jamanetwork.com/journals/jama/fullarticle/2736563
    Hahn JH, Song YB, Oh JH et al Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention. The SMART-CHOICE Randomized Clinical Trial. JAMA. 2019;321(24):2428-2437 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31237645 https://jamanetwork.com/journals/jama/fullarticle/2736564
    Ziada KM, Moliterno DJ. Dual Antiplatelet TherapyIs It Time to Cut the Cord With Aspirin? JAMA. 2019;321(24):2409-2411 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31237621 https://jamanetwork.com/journals/jama/fullarticle/2736537
  19. 19.0 19.1 Yin SHL, Xu P, Wang B et al Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis. BMJ 2019;365:l2222 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31253632 Free Article https://www.bmj.com/content/365/bmj.l2222
  20. 20.0 20.1 Steg PG, Bhatt DL, Simon T et al. Ticagrelor in patients with stable coronary disease and diabetes. N Engl J Med 2019 Sep 1; PMID: https://www.ncbi.nlm.nih.gov/pubmed/31475798 https://www.nejm.org/doi/10.1056/NEJMoa1908077
  21. 21.0 21.1 Medical Knowledge Self Assessment Program (MKSAP) 19 American College of Physicians, Philadelphia 2022
  22. 22.0 22.1 Gao Y, Chen W, Pan Y, et al. Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke. N Engl J Med. 2023 Dec 28;389(26):2413-2424. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38157499 https://www.nejm.org/doi/10.1056/NEJMoa2309137
  23. 23.0 23.1 Swift Yasgur B Low LDL With DAPT Tied to High Bleeding Risk After Stroke. Medscape. March 21, 2024 https://www.medscape.com/viewarticle/low-ldl-dapt-tied-high-bleeding-risk-after-stroke-2024a10005a3
    Cheng A, Xue J, Wang A et al LDL-C Levels and Bleeding Risk in Patients Taking DAPT After Minor Ischemic Stroke or TIA. JAMA Neurol. 2024;81(4):354-362. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38436990 PMCID: PMC10913006 (available on 2025-03-04) https://jamanetwork.com/journals/jamaneurology/fullarticle/2815831
  24. 24.0 24.1 24.2 Guan L, Han S, Johnston SC et al Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack. Neurology. 2024 Oct 8;103(7):e209845. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39270151 Clinical Trial.